SEC Form 4 · accession 0001179110-15-011896

ABIOMED INC · ABMD

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

William J Bolt

Officer — SVP, QA and Regulatory Affairs

Period of report

Aug 6, 2015

Accepted (ET)

Aug 7, 2015 · 4:45 pm EDT

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0000815094

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I
Common Stock, $.01 par^F4	Aug 6, 2015	M	30,000	$10.03	A	128,325	D
Common Stock, $.01 par^F4,F5	Aug 6, 2015	S	3,800	$92.794	D	124,525	D
Common Stock, $.01 par^F4,F6	Aug 6, 2015	S	6,800	$93.5479	D	117,725	D
Common Stock, $.01 par^F4,F7	Aug 6, 2015	S	5,994	$94.7648	D	111,731	D
Common Stock, $.01 par^F4,F8	Aug 6, 2015	S	11,446	$95.7277	D	100,285	D
Common Stock, $.01 par^F4,F9	Aug 6, 2015	S	9,860	$96.681	D	90,425	D
Common Stock, $.01 par^F4	Aug 6, 2015	S	100	$97.36	D	90,325	D

Table II — derivative securities

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Owned after	D/I
Stock Option (right to buy)^F2,F4,F1	$10.03	Aug 6, 2015	M	30,000	D	Jun 3, 2011	Jun 3, 2020	Common Stock	0	D
Stock option (right to buy)^F2,F1	$13.80	holding	—	—	—	May 23, 2009	May 23, 2018	Common Stock	9,666	D
Stock Option (right to buy)^F2,F1	$22.44	holding	—	—	—	May 22, 2013	May 22, 2022	Common Stock	20,000	D
Stock Option (Right to Buy)^F2,F1	$23.15	holding	—	—	—	May 14, 2014	May 14, 2023	Common stock	20,000	D
Stock Option (Right to Buy)^F2,F3	$21.55	holding	—	—	—	May 14, 2015	May 14, 2024	Common Stock	15,000	D
Stock Option (Right to Buy)^F2,F3	$66.25	holding	—	—	—	May 13, 2016	May 13, 2025	Common Stock	6,000	D

Explanation of responses

F1These options become exercisable in annual 25% increments, commencing on the date shown in Table II, Column 6.
F2Grant to reporting person of this option to buy the number of Common Stock set forth in Table II, Column 7, under the ABIOMED, Inc. 2008 Stock Incentive Plan.
F3These options become exercisable in annual 33-1/3% increments, commencing on the date shown in Table II, Column 6.
F4Sale of common stock pursuant to reporting owner's 10b5-1 plan.
F5This price represents the weighted average sale price of multiple transactions on the reported date at prices that ranged between $92.5000 and $92.9900. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.
F6This price represents the weighted average sale price of multiple transactions on the reported date at prices that ranged between $93.0000 and $93.9750. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.
F7This price represents the weighted average sale price of multiple transactions on the reported date at prices that ranged between $94.2200 and $95.2000. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.
F8This price represents the weighted average sale price of multiple transactions on the reported date at prices that ranged between $95.2900 and $96.2600. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.
F9This price represents the weighted average sale price of multiple transactions on the reported date at prices that ranged between $96.2900 and $97.2300. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.